12 results
Early Breast Cancer - Management Algorithm

#breast #cancer #malignancy #algorithm #oncology #early
Early Breast Cancer ... - Management Algorithm ... #breast #cancer ... #malignancy #algorithm ... #oncology #early
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
Differential Diagnosis Algorithm ... Posterior •TB ... ) • Cancer (In ... Infection • Cancer ... Causes #Hematology #Oncology
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... - Management Algorithm ... #Cancer #Management ... #Algorithm #treatment ... #oncology
Cavitary Lung Disease - Differential Diagnosis and Workup Algorithm
Acute / Subacute:
 • Acute Infections: Lung abscess,
Diagnosis and Workup Algorithm ... Chronic Infections: TB ... Parasitic, Viral • Malignancy ... : Primary lung cancer ... #lesion #pulmonary
Lymphadenopathy - Differential Diagnosis Algorithm
Localized: 
 • Cervical: EBV, CMV, HIV, Toxo, TB, Lymphoma, Head /
Differential Diagnosis Algorithm ... CMV, HIV, Toxo, TB ... scratch, Tularemia), Breast ... Cancer • Supraclavicular ... tuberculosis • Malignant
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
thrombosis; PE = pulmonary ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Lung Nodule - Differential Diagnosis Algorithm
Nodule on > 2 Years Without a Change in Size:
 •
Differential Diagnosis Algorithm ... Solitary Nodule: • Malignant ... • Primary lung cancer ... Colon, Kidney, Breast ... #Causes #Pulmonary
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... • HIV: 2/3 pulmonary ... tracheobronchial stenosis, malignancy ... , and chronic pulmonary ... #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Lymphoma • Lung cancer ... • HIV: 2/3 pulmonary ... tracheobronchial stenosis, malignancy ... , and chronic pulmonary ... #Diagnosis #Management